Dialysate CA125 in stable CAPD patients: no relation with transport parameters
- PMID: 8575125
Dialysate CA125 in stable CAPD patients: no relation with transport parameters
Abstract
We investigated dialysate CA125 concentrations (dCA125) and its possible relation to transport parameters in 67 stable CAPD patients. dCA125 can be regarded as a reflection of mesothelial cell mass or mesothelial cell turn-over. In every patient a standard peritoneal permeability analysis (SPA) was done. dCA125 was determined in the effluent of all SPA's. The examinations were done during a 4 h dwell with glucose 1.36%. In 29 tests dextran 70(milligrams) was added for fluid kinetics. dCA125 was positively related to age (p = 0.03) and negatively to the duration of CAPD (p = 0.0003). No correlation existed with peritonitis incidence (p = 0.21). Also, no relationship was present with the mass transfer area coefficient of creatinine, or with net ultrafiltration. The intrinsic permeability to macromolecules, expressed as the restriction coefficient (rc) was also not related to dCA125 (p = 0.14). Data on fluid kinetics showed that neither transcapillary ultrafiltration rate, effective lymphatic absorption rate, the change in intraperitoneal volume (delta IPV) nor glucose absorption were related to dCA125. A subgroup of patients (n = 20) had low CA125 values (< 11 U/ml). They were treated with CAPD for a longer period of time (23 vs 16 months, p = 0.02), and had a higher rc (2.59 vs 2.23, p < 0.0001). The relationship between low dCA125 and duration of CAPD can possibly be explained by vanishing of the mesothelial layer, as has been reported in patients on long-term CAPD. The higher rc of the low dCA125 group is probably also related to duration of CAPD, and not directly to the mesothelial cell mass, as the mesothelium is no osmotic barrier and because no pathophysiological mechanism can explain the relationship between a low mesothelial cell mass and a low permeability to macromolecules. It can be concluded that mesothelial cell mass is negatively related to the duration of CAPD treatment, but mesothelial cells are unlikely to play an important role in transport kinetics.
Similar articles
-
The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis.Adv Perit Dial. 2003;19:24-7. Adv Perit Dial. 2003. PMID: 14763029
-
The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.Ren Fail. 2008;30(2):161-7. doi: 10.1080/08860220701808384. Ren Fail. 2008. PMID: 18300115
-
Dialysate cancer antigen 125 levels in children treated with peritoneal dialysis.Adv Perit Dial. 2000;16:328-31. Adv Perit Dial. 2000. PMID: 11045322
-
Evaluation of peritoneal membrane integrity.J Nephrol. 1997 Sep-Oct;10(5):238-44. J Nephrol. 1997. PMID: 9364314 Review.
-
Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis.Perit Dial Int. 2001 Nov-Dec;21(6):560-7. Perit Dial Int. 2001. PMID: 11783764 Review.
Cited by
-
Dialysate CA125 levels in children on continuous peritoneal dialysis.Pediatr Nephrol. 2005 Nov;20(11):1615-21. doi: 10.1007/s00467-005-2007-5. Epub 2005 Aug 20. Pediatr Nephrol. 2005. PMID: 16133054
-
Treatment of severe ultrafiltration failure with nonglucose dialysis solutions in patients with and without peritoneal sclerosis.NDT Plus. 2008 Oct;1(Suppl 4):iv63-iv70. doi: 10.1093/ndtplus/sfn127. NDT Plus. 2008. PMID: 25983990 Free PMC article.
-
Encapsulating peritoneal sclerosis: the state of affairs.Nat Rev Nephrol. 2011 Aug 2;7(9):528-38. doi: 10.1038/nrneph.2011.93. Nat Rev Nephrol. 2011. PMID: 21808281 Review.
-
Characterization of peritoneal dialysis effluent-derived cells: diagnosis of peritoneal integrity.J Artif Organs. 2013 Mar;16(1):74-82. doi: 10.1007/s10047-012-0673-1. Epub 2012 Dec 30. J Artif Organs. 2013. PMID: 23274627
-
Dialysate cancer antigen 125 in long-term peritoneal dialysis patients.Clin Exp Nephrol. 2014 Feb;18(1):10-5. doi: 10.1007/s10157-013-0823-7. Epub 2013 Jun 12. Clin Exp Nephrol. 2014. PMID: 23757048 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous